A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

BACKGROUND: Platinum-based two-drug combination chemotherapy has been standard of care for patients with advanced nonsmall-cell lung cancer (NSCLC). The primary aim was to compare overall survival (OS) of patients with advanced NSCLC between the two chemotherapy regimens. Secondary end points includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, K., Sakai, H., Katakami, N., Nishio, M., Inoue, A., Okamoto, H., Isobe, H., Kunitoh, H., Takiguchi, Y., Kobayashi, K., Nakamura, Y., Ohmatsu, H., Sugawara, S., Minato, K., Fukuda, M., Yokoyama, A., Takeuchi, M., Michimae, H., Gemma, A., Kudoh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478975/
https://www.ncbi.nlm.nih.gov/pubmed/25908605
http://dx.doi.org/10.1093/annonc/mdv190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478975/
https://www.ncbi.nlm.nih.gov/pubmed/25908605
http://dx.doi.org/10.1093/annonc/mdv190

Ejemplares similares